Saudi Arabia sets new packaging and labelling rules for cosmetics in ampoules and vials.
Dubai: Saudi Arabia’s Food and Drug Authority (SFDA) will prohibit cosmetic products intended for external use from being sold in syringe-style packaging from January 1, 2027, as part of measures to prevent them from being mistaken for injectable pharmaceutical products.
In a circular addressed to cosmetic manufacturers and importers, the SFDA said it had identified externally applied cosmetic products being marketed in packaging resembling pharmaceutical formats, including syringes, ampoules and vials.
Under the new rules, cosmetics packaged in syringes will be prohibited from being placed on the Saudi market.
Cosmetic products sold in ampoules and vials will continue to be permitted, but both their inner and outer packaging must display clear warnings in Arabic and English stating that the product is intended for external cosmetic use only and must not be injected.
The labels must also advise users to avoid contact with the eyes and exercise caution when opening the product.
The SFDA has also prohibited advertising, promotional and marketing materials that state or imply that such products can be administered by injection or through any other device that penetrates the skin.
Manufacturers, importers and other establishments have until December 31, 2026, to withdraw products covered by the circular from the market or make the necessary changes to ensure compliance with the new requirements.
The authority said legal action would be taken against products and establishments that fail to comply after the deadline. The new measures will come into effect on January 1, 2027, following the end of the grace period.
